Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27456297 | 0.98 | ALDH1A1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL25680759 | 0.98 | ALDH1A1 (0.42) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL24377092 | 0.97 | HSD17B1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL25680775 | 0.96 | ALDH1A1 (0.46) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL27455712 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL17655849 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL17655973 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL27455921 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL23633560 | 0.95 | MAPT (0.43) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 | |
| SCHEMBL27252663 | 0.94 | ALDH1A1 (0.47) | ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690292-B2 | Organic electronic element comprising a compound for organic electronic element and an electronic device thereof | ESR1, EML4, ORAI2 | ALDH1A1 601/4885KDM4E 877/4885TP53 3852/4885 |
| US-20230129535-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | ESR1, EML4, ORAI2 | ALDH1A1 601/4885KDM4E 877/4885TP53 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.